[{"address1": "1 Enterprise Drive", "address2": "Suite 430", "city": "Shelton", "state": "CT", "zip": "06484-4779", "country": "United States", "phone": "203-221-7381", "fax": "203-557-3023", "website": "https://www.intensitytherapeutics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs in the United States. Its lead product candidate includes INT230-6, which is in human clinical studies for the treatment of refractory solid tumors, such as soft tissue sarcoma which is in phase 3 trails; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lewis H. Bender M.A., M.B.A., M.S.", "age": 64, "title": "Founder, President, CEO & Chairman of the Board", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 1235740, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Talamo CPA, M.B.A.", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 252244, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Wesolowski CPA, M.B.A.", "age": 63, "title": "Principal Accounting Officer & Controller", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 272371, "exercisedValue": 0, "unexercisedValue": 99575}, {"maxAge": 1, "name": "Mr. James M. Ahlers", "age": 59, "title": "Executive Vice President of Corporate Finance", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 75088, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Schwartz M.D.", "title": "Executive Vice President of Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.22, "open": 4.2146, "dayLow": 4.1501, "dayHigh": 4.28, "regularMarketPreviousClose": 4.22, "regularMarketOpen": 4.2146, "regularMarketDayLow": 4.1501, "regularMarketDayHigh": 4.28, "forwardPE": -2.691824, "volume": 1624, "regularMarketVolume": 1624, "averageVolume": 11635, "averageVolume10days": 3960, "averageDailyVolume10Day": 3960, "marketCap": 58943736, "fiftyTwoWeekLow": 2.01, "fiftyTwoWeekHigh": 11.44, "fiftyDayAverage": 4.6375, "twoHundredDayAverage": 4.70489, "currency": "USD", "enterpriseValue": 53543128, "floatShares": 6344417, "sharesOutstanding": 13771900, "sharesShort": 19842, "sharesShortPriorMonth": 35237, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.47160998, "heldPercentInstitutions": 0.12189999, "shortRatio": 1.3, "shortPercentOfFloat": 0.0021, "bookValue": 0.39, "priceToBook": 10.9743595, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -15075000, "trailingEps": -0.24, "forwardEps": -1.59, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "INTS", "underlyingSymbol": "INTS", "shortName": "Intensity Therapeutics, Inc.", "longName": "Intensity Therapeutics, Inc.", "firstTradeDateEpochUtc": 1688131800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "8f52e929-8b6e-361a-bf1e-4405bee2d3bf", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.28, "targetHighPrice": 16.0, "targetLowPrice": 12.0, "targetMeanPrice": 14.0, "targetMedianPrice": 14.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 6324000, "totalCashPerShare": 0.459, "totalDebt": 151000, "quickRatio": 1.974, "currentRatio": 2.322, "debtToEquity": 2.825, "returnOnAssets": -0.72744006, "returnOnEquity": -1.47227, "freeCashflow": 9662015, "operatingCashflow": -14645000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]